Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$806M |
| 2 |
AbbVie
ABBV
|
+$481M |
| 3 |
T-Mobile US
TMUS
|
+$464M |
| 4 |
Kroger
KR
|
+$430M |
| 5 |
Baidu
BIDU
|
+$423M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.35B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.26B |
| 3 |
S
Sprint Corporation
S
|
+$675M |
| 4 |
Amgen
AMGN
|
+$488M |
| 5 |
Humana
HUM
|
+$450M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.76% |
| 2 | Technology | 16.41% |
| 3 | Consumer Staples | 10.58% |
| 4 | Consumer Discretionary | 10.13% |
| 5 | Communication Services | 9.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1176
Westwood Holdings Group
WHG
$184M
| $10.7M | 0.01% |
679,558
+10,342
| +2% | +$197K |
|
1177
Voyager Therapeutics
VYGR
$198M
| $10.7M | 0.01% |
845,680
-197,121
| -19% | -$2.29M |
|
|
GSS
1178
DELISTED
Golden Star Resources Ltd.
GSS
| $10.7M | 0.01% |
3,675,028
+1,614,290
| +78% | +$4.19M |
|
1179
Rigel Pharmaceuticals
RIGL
$781M
| $10.6M | 0.01% |
581,768
+160,856
| +38% | +$2.89M |
|
1180
Mesa Laboratories
MLAB
$622M
| $10.6M | 0.01% |
49,100
+15,200
| +45% | +$3.5M |
|
|
SEE
1181
DELISTED
Sealed Air
SEE
| $10.6M | 0.01% |
323,909
-22,500
| -6% | -$676K |
|
|
FPRX
1182
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $10.6M | 0.01% |
1,744,048
-227,869
| -12% | -$939K |
|
1183
HUB Group
HUBG
$2.53B
| $10.6M | 0.01% |
+444,272
| New | +$10.3M |
|
1184
World Acceptance Corp
WRLD
$912M
| $10.6M | 0.01% |
161,925
-53,375
| -25% | -$3.34M |
|
|
ANH
1185
DELISTED
Anworth Mortgage Asset Corporation
ANH
| $10.6M | 0.01% |
6,234,590
-670,300
| -10% | -$1.04M |
|
|
LCI
1186
DELISTED
Lannett Company, Inc.
LCI
| $10.6M | 0.01% |
364,784
+93,175
| +34% | +$2.9M |
|
|
GOGL
1187
DELISTED
Golden Ocean Group
GOGL
| $10.6M | 0.01% |
2,720,769
-980,832
| -26% | -$3.44M |
|
1188
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
$46.7B
| $10.5M | 0.01% |
115,150
+28,000
| +32% | +$2.56M |
|
|
NATI
1189
DELISTED
National Instruments Corp
NATI
| $10.5M | 0.01% |
271,866
-46,800
| -15% | -$1.77M |
|
1190
Highwoods Properties
HIW
$3.51B
| $10.5M | 0.01% |
281,700
-729,402
| -72% | -$27.1M |
|
1191
Star Bulk Carriers
SBLK
$3.25B
| $10.5M | 0.01% |
1,591,826
-219,200
| -12% | -$1.26M |
|
1192
CACI
CACI
$14.8B
| $10.5M | 0.01% |
48,400
-3,200
| -6% | -$765K |
|
1193
Texas Capital Bancshares
TCBI
$4.41B
| $10.5M | 0.01% |
339,900
+35,600
| +12% | +$997K |
|
1194
Repay Holdings
RPAY
$307M
| $10.5M | 0.01% |
+425,200
| New | +$8.57M |
|
1195
American Superconductor
AMSC
$1.58B
| $10.4M | 0.01% |
1,282,317
+121,900
| +11% | +$797K |
|
1196
Guardant Health
GH
$21.2B
| $10.4M | 0.01% |
+128,300
| New | +$10.3M |
|
|
ECOM
1197
DELISTED
CHANNELADVISOR CORPORATION
ECOM
| $10.4M | 0.01% |
656,909
+86,700
| +15% | +$1M |
|
1198
AGNC Investment
AGNC
$13.1B
| $10.4M | 0.01% |
+803,929
| New | +$10.1M |
|
|
QUOT
1199
DELISTED
Quotient Technology Inc
QUOT
| $10.4M | 0.01% |
1,416,200
+172,200
| +14% | +$1.15M |
|
|
PCTI
1200
DELISTED
PCTEL, Inc. Common Stock
PCTI
| $10.4M | 0.01% |
1,549,937
+153,999
| +11% | +$984K |
|
Similar funds
Jim Simons's Q2 2020 Portfolio in Review
As of Q2 2020, Jim Simons held 3,987 positions worth $116B, up 13% from $103B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Jim Simons withdrew a net $8.24B in Q2 2020, closing 596 positions and reducing 1,366 holdings. Its most notable exit was Allergan plc, an estimated $1.26B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 26% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, Jim Simons opened a new position in Uber worth $187M.
- Jim Simons's largest Q2 2020 buy was Uber: 6,030,316 shares worth $187M.
- Jim Simons added most to Zoom in Q2 2020, an estimated $806M increase.
- Jim Simons's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $1.35B.
- Jim Simons fully exited Allergan plc in Q2 2020, selling an estimated $1.26B.
- Jim Simons's ten largest holdings make up 14% of its $116B portfolio in Q2 2020.
- Jim Simons opened 584 new positions and closed 596 in Q2 2020.
- Jim Simons's portfolio value rose 13% quarter-over-quarter to $116B.
Based on Renaissance Technologies's 13F filing for Q2 2020, filed 13 Aug 2020.